Agoracom Blog Home

Author Archive

« Older Entries
Newer Entries »

$KABN.ca North America Announces That Its Non-Brokered Private Placement Financing for Up to $2M Is Oversubscribed and Has Been Upsized to $3M $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 8:41 AM on Wednesday, December 16th, 2020
kabn-square-new
  • Announced that it has received subscription confirmations for over $2 Million of units pursuant to the non-brokered financing announced on December 10, 2020, which is expected to close prior to the unrelated, best efforts brokered private placement of units which the Company previously announced on December 7, 2020.
  • To support the current demand, the Company has upsized the Non-Brokered Offering by an additional $1 Million.
  • This amount has already been fully committed, subject to the receipt of outstanding subscription documents and all necessary approvals.

TORONTO, ON / December 16, 2020 / KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America” or “KABN NA“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has received subscription confirmations for over $2 Million of units (“Units“) pursuant to the non-brokered financing (the “Non-Brokered Offering“) announced on December 10, 2020, which is expected to close prior to the unrelated, best efforts brokered private placement (the “Brokered Offering“) of units which the Company previously announced on December 7, 2020. To support the current demand, the Company has upsized the Non-Brokered Offering by an additional $1 Million. This amount has already been fully committed, subject to the receipt of outstanding subscription documents and all necessary approvals.

The gross proceeds of these unrelated offerings together will now be up to $4.15 Million. The Units in each of the Brokered Offering and Non-Brokered Offering are being offered at $0.15 per Unit, with each Unit comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant shall be exercisable to acquire one Common Share (a “Warrant Share“) at an exercise price of $0.20 per Warrant Share for a period of 24 months from the applicable closing.

The Brokered Offering is expected to close on or about December 29, 2020, or on such earlier date as agreed upon between the Company and Agent, and the Non-Brokered Offering is expected to close on or about December 21, 2020, or on such earlier or later date as the Company determines, and each is subject to certain conditions, including receipt of subscription agreements and payment of the subscription amounts by subscribers. The Units to be issued will have a hold period of four months and one day from the applicable closing.

The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.

The Company also announces that Mr. Rav Mlait has resigned from the Board of Directors to further focus his efforts on his current commitments. The Company thanks Mr. Mlait for all his support with the public listing process earlier this year, and wishes him well in his current and future endeavors.

About KABN North America
KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN NA’s propriety technology suite includes 4 key products:

Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their Self Sovereign Identity and to use Liquid Avatars to share verifiable credentials, including access, identity and designation credentials, and public and permission based private data when they want and with whom they want.

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.

KABN KASH is a cashback, loyalty and engagement program that powers the KABN NA’s revenue ecosystem. KABN NA provides its products and services at no cost to consumers and generates revenues through permission-based partner programs.

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

KABN Systems NA Holding Corp. is a publicly listed company listed on the Canadian Securities Exchange under the symbol “KABN”.

For further information, please contact:
David Lucatch
647-725-7742 Ext. 701
[email protected]

Tags: , , , , , , , ,
Posted in KABN, KABN Systems NA Holdings Corp. | Comments Off on $KABN.ca North America Announces That Its Non-Brokered Private Placement Financing for Up to $2M Is Oversubscribed and Has Been Upsized to $3M $MOS.ca $MOGO.ca $CTZ.ca

Datametrex AI $DM.ca $DTMXF Announces Release of Nexalogy “SMART” Technology $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:28 AM on Wednesday, December 16th, 2020
  • Announced the release of Nexalogy SMART – Social Media Automated Reporting Technology
  • As previously announced, Nexalogy’s SMART is an advanced proprietary AI technology
  • SMART minimizes human involvement in data analysis and reporting.
  • It significantly decreases the time required for integration and interpretation of large data sets and report production
  • Now fully available

Toronto, Ontario–(December 16, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce the release of Nexalogy SMART – Social Media Automated Reporting Technology.

As previously announced, Nexalogy’s SMART is an advanced proprietary AI technology. SMART minimizes human involvement in data analysis and reporting. It significantly decreases the time required for integration and interpretation of large data sets and report production. It is now fully available.

SMART takes NexaIntelligence to the next level with AI-powered automated reporting technology. It quickly generates reports with all of NexaIntelligence’s visualizations, augmenting the reporting capacity of analysts. Human resources are a scarce commodity. SMART integrates larger sets of data into smaller, more manageable reports, thus significantly reducing the number of resource hours required to identify insights.

Our AI pre-reads text, selects verbatims, and summarizes themes quickly, reliably, and with precision. The AI technology creates powerful reports based on our algorithms and automatically selects the most important original posts to include, in minutes rather than hours. Analysts can specify filters on the data to get automatic reports on subsets of the data focusing on specific times, entities, social media users, or topics. This means social media trends can be understood faster and with less difficulty, keeping companies ahead of the curve.

SMART’s scheduling functionality allows companies to structure reporting to match regular schedules as needed or in response to triggering events in the data itself. AI-written reports are emailed to analysts inconvenient and easy to read file formats, such as MSWORD or PDF. Raw JSON outputs from Nexalogy’s API are also available for use in white labelled products.

AI reporting on social media and other forms of unstructured text is increasingly important and relevant in the information landscape. The need for strategic reporting of data from these platforms in both the public and private sectors is growing at a rapid pace. The ability to analyze and monetize social media discussions, as well as unstructured text from owned sources, are key strengths of SMART. Breaking through information bottlenecks and resource limitations, SMART can take big data discovery and exploration to a new level of actionable insights.

“Our AI helps you unlock the power of discovery, converting unknown unknowns into known knowns, activating the hidden potential currently lost in big data. With social media and unstructured text being a key facet of how businesses and consumers connect during the pandemic, we feel SMART is uniquely positioned to assist clients in unlocking potential in current verticals and exploring the potential of new verticals; for security, we help you discover unknown problems so you can squash them before they become big problems. For growth, we help you discover and unlock hidden potential,” said Marshall Gunter, CEO of Datametrex AI Limited.

To see more and download example reports, click here: https://nexalogy.com/product/

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

###

Tags: , , , , , , , ,
Posted in All Recent Posts, Datametrex AI Limited, Featured | Comments Off on Datametrex AI $DM.ca $DTMXF Announces Release of Nexalogy “SMART” Technology $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Kontrol $KNR $KNR.ca $KNR.c $KNRLF Completes Debenture Exchange and Announces Intention to Begin Process of Uplisting to Major North American Stock Exchanges $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 7:22 AM on Wednesday, December 16th, 2020
kontrol-logo
  • Company’s board of directors has authorized management to review the process to graduate the Company from the CSE to the TSX
  • If the Company is successful in uplisting to the TSX, Kontrol intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States, which will enable Kontrol to apply to be listed on the NASDAQ

TORONTO, ON / December 16, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that it has completed its previously announced debenture exchange (see press release dated June 9, 2020 and November 2, 2020) by private placement. The 2020 Debenture holders exchanged a total of $3,650,000 for 2022 Debentures and new proceeds of $871,000 were raised. The remaining 2020 Debenture balance of $2,061,000 was redeemed in cash by the Company. Each unit is comprised of one $1,000 8% unsecured debenture (and non-convertible) of the Company maturing on October 31, 2022 and 10 common shares.

Paul Ghezzi, CEO of Kontrol, commented:

“With the exchange of the 2020 Debentures we have improved the balance sheet and the Company’s net equity position. As we continue to execute on our business plan, we believe this is an opportune time to begin the graduation process to the senior North American exchanges for an uplisting in 2021.”

Name Change

Further to the passing of a resolution of shareholders at its most recent general and special meeting of shareholders, the Company intends to proceed with a corporate name change to “Kontrol Technologies Corp.”, which is anticipated to be completed prior to December 31, 2020.

Uplisting to TSX, NASDAQ

The Company’s board of directors has authorized management to review the process to graduate the Company from the CSE to the TSX. If the Company is successful in uplisting to the TSX, Kontrol intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States (the “SEC“), which will enable Kontrol to apply to be listed on the NASDAQ.

Completion of any uplisting is subject to meeting certain conditions, as well as the approval of the TSX. There is no assurance that the TSX will approve the listing application or that Kontrol will complete the uplisting as contemplated. There is no assurance that either the SEC or NASDAQ will approve the Company’s respective applications or that Kontrol will complete the listing to the NASDAQ as proposed.

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

Tags: , , , , , , , ,
Posted in Featured, Kontrol Energy Corp. | Comments Off on Kontrol $KNR $KNR.ca $KNR.c $KNRLF Completes Debenture Exchange and Announces Intention to Begin Process of Uplisting to Major North American Stock Exchanges $SNE $MSFT $HON $GOOGL $QCOM

CardioComm Solutions $EKG.ca to Bring #ECG Monitoring to Remote Patient and #COVID-19 Monitoring Platforms $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 8:38 PM on Tuesday, December 15th, 2020
  • Entered into a technology integration agreement with LiveCare Corp. and a Value-Added Reseller and Distribution Agreement with Alliance Tele-Med, to provide integrated ECG monitoring through the LiveCare Link+ device and telemedicine platform.
  • CardioComm confirms integration of their FDA and Health Canada cleared GEMS™ ECG management software, the wireless HeartCheck™ CardiBeat ECG monitor and access to the SMART Monitoring ECG reading service into the Link+ platform has been completed.
  • Under the agreement, the GEMS™ Mobile app technology was embedded into the Link+ gateway device allowing ECGs to be transferred through the Link+ platform to the CardioComm SMART Monitoring ECG reading service.
  • Once an ECG report is completed, the report findings are then securely transmitted to the Link+ platform and from there to the Link+ platform’s remote patient monitoring teams.

TORONTO, ON / December 15, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) (“CardioComm” or the “Company“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) device and software solutions, is pleased to confirm it has entered into a technology integration agreement with LiveCare Corp. (“LiveCare“) and a Value-Added Reseller and Distribution Agreement with Alliance Tele-Med (“Alliance“), to provide integrated ECG monitoring through the LiveCare Link+ device and telemedicine platform.

CardioComm confirms integration of their FDA and Health Canada cleared GEMS™ ECG management software, the wireless HeartCheck™ CardiBeat ECG monitor and access to the SMART Monitoring ECG reading service into the Link+ platform has been completed. Under the agreement, the GEMS™ Mobile app technology was embedded into the Link+ gateway device allowing ECGs to be transferred through the Link+ platform to the CardioComm SMART Monitoring ECG reading service. Once an ECG report is completed, the report findings are then securely transmitted to the Link+ platform and from there to the Link+ platform’s remote patient monitoring teams.

Link+ is a patented smart home gateway that integrates multiple key medical bio-sign monitoring devices in a patient’s home through a proprietary, touch-free device which is always connected to the 4G network. There is no need for patients to connect to any specific Wi-Fi network for the Link+ to fully operate and, once activated, the Link+ transmits data directly to LiveCare’s HIPAA compliant cloud. The Link+ is fully reimbursable through Medicare, Medicaid and many commercial insurance plans using multiple CPT codes.

Through the addition of the GEMS™ technology into the Link+ gateway device, the Link+ device will be capable of recognizing multiple ECG devices with up to 12 leads of ECG recording and provide Link+ customers with more options in choosing a device of their preference. The HeartCheck™ CardiBeat will be the recommended device for remote ECG patient monitoring given its availability in Canada, the US and Europe. All recorded ECGs will be passed through CardioComm’s SMART Monitoring ECG triaging service. ECG reports confirming the presence or absence of an arrhythmia will be provided to Link+ users.

The Link+ platform with ECG monitoring sales and marketing will be undertaken exclusively by Alliance with a focus on monitoring patients with or suspected to have COVID-19. Sales into the US is where the primary marketing efforts are targeted for 2021. CardioComm will see revenue from the sales of the HeartCheck™ CardiBeat ECG devices as well as from ECG triaging service fees.

To learn more about CardioComm’s products and for further updates regarding HeartCheck™ ECG device integrations please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485:2016 MDSAP certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

About LiveCare (www.livecareusa.com)

LiveCare’s mission is to improve patient outcomes, lower healthcare costs, and reduce hospital readmissions by developing technology to assist patients and providers during the critical transitional care period. LiveCare’s technology improves patient compliance with post-discharge medical protocols and enhances engagement between patients and providers. With a team of experienced professionals working in research and development, sales, and other capacities, LiveCare is putting the needs of patients and providers at the forefront as it moves the RPM market forward from its corporate headquarters in New York City.

About Alliance-Telemed, LLC

Alliance Tele-Med is a US-based Value-Added Wholesaler & Reseller of state-of-the-art remote patient monitoring (RPM) technology and care management services solutions for domestic and international healthcare delivery organizations and their patients. The company engages with healthcare and life sciences organizations such as Independent and Hospital-Owned Medical Practices, Independent Hospitals and Health Systems, Accountable Care Organizations (ACO’S), Independent Physician Associations (IPA’s), Provider Networks, large Employer Groups and Third Party Administrators, Clinics, FQHC and Regional Health Centers, Senior ‘Aging in Place’ Companies and Facilities such as Assisted Living Facilities, Nursing Homes, Skilled Nursing Facilities, Home Health Companies, pharmaceutical companies, and Clinical Research Organizations (CRO’s).

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
[email protected]
[email protected]

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , , , , , ,
Posted in CardioComm Solutions | Comments Off on CardioComm Solutions $EKG.ca to Bring #ECG Monitoring to Remote Patient and #COVID-19 Monitoring Platforms $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

FansUnite Entertainment $FANS.ca $FUNFF Announces up to Approximately $5.0 Million Brokered Private Placement of Special Warrants Led by Gravitas Securities Inc. $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 5:06 PM on Tuesday, December 15th, 2020
  • Announced that ‎it has entered into an agreement with Gravitas Securities Inc., as sole agent ‎and sole bookrunner, in connection with a marketed commercially reasonable best efforts ‎private ‎placement offering of special warrants of the Company at a price of $0.625 per Special Warrant, for gross proceeds of up to approximately $5,000,000.‎
  • The initial closing date is expected to be on or about the week of January 11th, 2021 and the Offering may be completed in one or more closings at the discretion of the Lead Agent. ‎

Vancouver, British Columbia–(December 15, 2020) –  FansUnite ‎Entertainment Inc. (CSE: FANS) (OTCB: FUNFF‎) (“FansUnite” or the “Company“), a ‎technology company providing leading online gaming solutions‎, is pleased to announce that ‎it has entered into an agreement with Gravitas Securities Inc., as sole agent ‎and sole bookrunner (the “Lead Agent“), in connection with a marketed commercially reasonable best efforts ‎private ‎placement offering (the “Offering“) of special warrants of the Company (“Special ‎Warrants“) at a price of $0.625 per Special Warrant, for gross proceeds of up to approximately $5,000,000.‎ The initial closing date is expected to be on or about the week of January 11th, 2021 (the “Closing Date” or “Closing“) and the Offering may be completed in one or more closings at the discretion of the Lead Agent. ‎

Each Special Warrant shall be exercisable, for no additional consideration at the option of the holder, ‎into one unit of the Company (each, a “Unit“), with each Unit being comprised of one common share ‎of the Company (a “Common Share“) and one half (1/2) of one non-transferable Common Share purchase warrant (each whole warrant‎, a “Warrant“). Each ‎Warrant will entitle the holder thereof to acquire one Common Share (each, a “Warrant Share“) at an ‎exercise price of $0.78 per Warrant Share for a period of 24 months after Closing (the “Expiry Date“).‎

The Company has granted the Lead Agent, as well as any other investment dealers or exempt market dealers agreeable to the Company that form a syndicate ‎of ‎agents with the Lead Agent (collectively with the Lead Agent, the “Agents“),‎ an option (the “Over-Allotment Option“) to offer for sale ‎up to an additional $750,000 of ‎Special Warrants issued pursuant to the Offering to cover any ‎over-allotments, exercisable in whole or in part, at any time within 30 days following the Closing Date.

The net proceeds raised under the Offering will be used for working capital and general corporate purposes.‎

As soon as reasonably practicable after the Closing, the Company will prepare and file with each of the securities ‎regulatory authorities in each of the provinces of British Columbia, Alberta, Manitoba and Ontario‎, (the “Jurisdictions“) and obtain a receipt for, a final short form ‎prospectus (the “Final Prospectus“), qualifying the distribution of the securities issued pursuant to the Offering, in compliance with applicable securities law, within sixty (60) days ‎from the Closing of the Offering.‎

In the event that the Company has not received a receipt for the Final Prospectus within ‎sixty (60) days following the Closing, each unexercised Special Warrant will thereafter ‎entitle the holder thereof to receive upon the exercise thereof, at no additional ‎consideration, one-and-one-tenth (1.10) Unit (instead of one Unit) ‎(the “Penalty Ratio“)‎, provided that nothing shall require the Company to issue fractional Units or ‎Common Shares and Warrant Shares underlying such Units, and any fractions resulting from the application of the Penalty Ratio shall be rounded down to the nearest whole number‎.‎

This press release is not an offer to sell or the solicitation of an offer to buy the securities in the ‎United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful ‎prior to qualification or registration under the securities laws of such jurisdiction. The securities ‎being offered have not been, nor will they be, registered under the United States Securities Act ‎of 1933, as amended, and such securities may not be offered or sold within the United States or ‎to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption ‎from U.S. registration requirements and applicable U.S. state securities laws.‎

About FansUnite Entertainment Inc.

FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one of a kind complete iGaming platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high growth potential in new or developing markets.

For further information, please contact:

Prit Singh Investor Relations at FansUnite
[email protected]
(905) 510-7636

Scott Burton Chief Executive Officer of FansUnite
[email protected]

Darius Eghdami President of FansUnite
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-‎looking information” under Canadian securities legislation. Generally, forward-looking information can be ‎identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” ‎‎”anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain ‎and forward-looking. Forward-looking statements may include, without limitation, statements relating to ‎future outlook and anticipated events such as: the Offering, the use of proceeds from the Offering, the filing and receipt for the Final Prospectus, the establishment of McBookie as a preeminent online ‎betting platform; the expansion of McBookie throughout the UK gambling industry; the effect of upcoming ‎sporting events on betting volume on the McBookie platform; the ‎Company’s unique portfolio of assets; and discussion of future plans, projections, objectives, estimates ‎and forecasts and the timing related thereto. Forward-looking statements are based on the Company’s ‎estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the ‎actual results, level of activity, performance or achievements of FansUnite to be materially different from ‎those expressed or implied by such forward-looking statements or forward-looking information. Additional ‎information regarding the risks and uncertainties relating to the Company’s business are contained under ‎the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, 2020 filed on its ‎issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, including the novel ‎coronavirus (COVID-19) global health pandemic, and the spread of other viruses or pathogens and influence ‎of macroeconomic developments. Accordingly, readers should not place undue reliance on forward-looking ‎statements and forward-looking information. The forward-looking statements in this news release are made ‎as of the date of this release. FansUnite disclaims and does not undertake to update or revise any forward-‎looking statements or forward-looking information, whether as a result of new information, future events or ‎otherwise, except as required by applicable securities laws.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES

Tags: , , , , , , , , , ,
Posted in FansUnite Entertainment Inc. | Comments Off on FansUnite Entertainment $FANS.ca $FUNFF Announces up to Approximately $5.0 Million Brokered Private Placement of Special Warrants Led by Gravitas Securities Inc. $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

MEDIA: The doctor will stream you now: How Binovi $VISN.ca $BNVIF is leading the charge in virtual vision therapy $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 4:27 PM on Tuesday, December 15th, 2020
  • The pandemic has created a new consumer expectation for virtual services
  • Tech company Binovi gives optometry patients a new alternative
  • With Binovi Connect, the company has created a seamless network for vision care professionals to work together

With 2020 becoming the year of the homebody, we’ve all had to drastically reduce our trips out of the house. While it’s been hard on everyone, we can consider ourselves lucky that there were already numerous resources to ease the transition into sheltering in place.

It’s no secret that companies bridging the distance between services like food delivery apps, and 24-hour product distribution have been the trend for a while now. Still, with communities shutting down, many newer services crossed the line from following the trend into being embedded into daily life.

While things like Zoom conferences and virtual personal training have been an infrequent occurrence pre-pandemic, consumers have realized that they’re now mainstream and accepted options to save time and social distance.

Office groups are even doing video-streamed murder mystery parties in place of their traditional in-person Christmas gatherings. It’s a new language of behaviour that we’re becoming fluent in as we continue to adapt to how COVID has changed our lives.

Even as restrictions lift and the curve eventually flattens, it’s hard to see a future without these new tools at consumers’ disposal. For instance, who would want to go back to sitting in a crowded waiting room, when you could simply have an online conference with your doctor? This Binovi Platform allows users to browse from a list of Binovi Providers, schedule appointments, conduct screening, and more.

It’s a shift that has already changed the healthcare industry. Specialist professionals can now maximize their patient schedule and keep appointments as socially distanced as possible. While it’s a handy change of pace, there has already been an opportunity to create a more accessible network to maximize efficiency and accuracy for both doctors and patients.


“Once a training regimen is established, along with a schedule for check-ins and evaluations, users can conduct their own training sessions.”

— Adam Cegielski, CEO, Binovi Technologies Corp.


Binovi offers the patient management resource that medical professionals have been waiting for

With one in four people worldwide living with issues related to vision that go beyond visual acuity, it’s time to address this gap and come up with an effective and efficient way for specialists to meet with patients during the pandemic and beyond.

Enter Binovi Technologies (TSXV: VISN | OTCQB: BNVIF), a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance.

Established to enhance how optometrists work with their patients and bring treatment into the 21st century, Binovi is supported by recognized optometry leaders worldwide.

This connection to vision therapists, occupational therapists, and physical therapists has led the company towards innovative testing methods that patients can do remotely. While in the presence of a professional, patients produce quantifiable data that Binovi can analyze, consult with other professionals about, and recommend the next steps for treatment.

Binovi’s experience with facilitating a channel between professionals and patients has led to the company’s latest telehealth innovation, Binovi Connect, which is a web-based video conferencing solution that connects consumers to vision care professionals focused on concussions, reading skills, and athletic enhancement.

The new application not only gives a straightforward service to both parties, but it provides a network for professionals to consult and collaborate with each other about specific patient treatments. It’s a streamlining of service that gives clarity and peace of mind to anyone who has felt like they might not have grasped everything their doctor has just said.

Patients can easily choose from specialists who best meet their needs, establish a routine with their selected one, and monitor in real-time the results they’ve made. On the other side of things, doctors can see notes from other professionals and collaborate on multiple fronts to create multi-tiered treatment tactics for shared patients.

It’s a program that has countless applications in the healthcare world, but for the moment, Binovi is remaining focused on vision-based therapy. With 800 clinics across the globe already using Binovi’s systems, their market share of the $74 billion a year Visioncare industry will only grow.
 

To do that, the company emphasizes the program’s ease of use and a clear value proposition. Binovi Connect is incredibly user-friendly, and patients are given everything they need to create progress.

“Once a training regimen is established, along with a schedule for check-ins and evaluations, users can conduct their own training sessions,” says Cegielski.

“This is happening while still under the watchful eye of their healthcare professionals who can monitor the results with session data stored in the cloud.”

Since the launch of this platform, the 800 organizations have created nearly 31,000 users, together completing more than 400,000 active sessions centered around the Binovi Library list of activities.

Niche treatments for niche ailments

When it comes to niche treatments, Binovi offers patients the materials they need as recommended by each doctor for treatment. This could be equipment for equilibrium building exercises or the means to conduct a supervised vision test.

Binovi Coach encourages and empowers patients to confidently complete their prescribed home therapy with clarity and guidance.

The insights from these sessional treatments are then boosted by the program’s AI. Cloud-based session data is effectively merged with data from the clinicians’ past findings, then offered to each patient’s current therapist. This allows each session to produce real-time suggestions, and present immediate resources to each therapist.

It’s a groundbreaking new approach to treatment, that has produced startling results for patients suffering from concussions, binocular vision dysfunction, amblyopia, and countless other afflictions. With Binovi, patients can actively improve dynamic visual acuity, visual reaction time, depth perception, and hand-eye/body-eye coordination.

The framework is already in place for patients to receive the specialized care they need regardless of geography or time zone. Now, it’s just a matter of time before consumer standards for virtual appointments and personal care reach a tipping point. Determining whether someone needs vision therapy, or could benefit from vision training, can start early.

When that happens, Binovi is ready to serve.

So, what’s next for the platform?

  • Migrating offline sessions to Binovi Connect
  • Inclusion of a broader class of providers
  • Support for more languages
  • Release of SDK for integration with other platforms
  • Anonymized data access for research
  • Expecting to launch a Beta version of the app by fiscal Q1 2021

“We are excited to continue to build out a robust telehealth platform as we continue our mission to be the leader in neuro-vision performance technology space.”

Why should investors take note of Binovi?

Binovi’s future innovation opportunities are largely driven by identifying high-value client needs and evaluating each unique opportunity to develop new products and services in the areas of neurotechnology and vision training to support unlocking human performance.

The company’s future innovation pipeline looks like this:

  • Expanding its capabilities within the education sector
  • Partnering with elite athletes, professional sports as well as esports teams
  • Standardizing data collection in the field to create optimized training regimens based on unique profiles, peer groups and custom goals
  • Working with military and law enforcement
  • Treating the aging population and improving performance for those affected by the impact of brain-related diseases or natural aging

Binovi’s innovation milestones from first acquiring Wayne Engineering in 2015 and its educational IP to commercializing its Binovi Connect Platform.

Additionally, the acquisition and integration of the VIMA Rev Strobe Lenses under the Binovi umbrella has provided Binovi with an additional toolset to expand its offering. Developed by Nike’s former Global Director of Vision Science and his team of sport science experts, the VIMA Rev Strobe Lenses are an integrated strobe training system that stimulates neuro-cognition through vision training.

VIMA’s technology is being integrated into Binovi’s product platform, with several orders already fulfilled. Current VIMA Rev strobe users include the NHL’s Colorado Avalanche, the NBA’s Golden State Warriors, Chicago Bulls and the Milwaukee Bucks.

Binovi has had a tremendous year so far, and they’re not done yet.

To learn more about the company, visit their website here.

Follow Binovi Technologies on social media:

Facebook
Twitter
LinkedIn
Instagram

Source: https://www.bnnbloomberg.ca/the-doctor-will-stream-you-now-how-binovi-is-leading-the-charge-in-virtual-vision-therapy-1.1536215

Tags: , , , , , ,
Posted in All Recent Posts, Binovi Technologies Corp. | Comments Off on MEDIA: The doctor will stream you now: How Binovi $VISN.ca $BNVIF is leading the charge in virtual vision therapy $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

AGORACOM Welcomes Valeo Pharma $VPH.ca $VPHIF With 7 Products To Be Launched In 2021 / 2022 ($45M. Estimated Peak Sales / Year) $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 3:31 PM on Tuesday, December 15th, 2020

(VPH: CSE) (VPHIF: OTCQB) (VP2: FSE)

www.valeopharma.com

Why Valeo Pharma?

  • Commercial stage revenue generating Canadian pharmaceutical company
  • Approaching EBITDA positive in coming months
  • 9 products currently marketed ($40M. estimated peak sales / year)
  • 7 additional products in pipeline ($45M. estimated peak sales / year)
  • In-license business model, no development or clinical risk
  • $1.5M in quarterly revenue ending July 31, 2020
  • $5.26M in revenue for 9 months ending July 31, 2020

What Exactly Does Valeo Pharma Do?

  • Acquires Canadian rights to commercial stage, innovative and proprietary drugs
  • Commercializes innovative prescription products in Canada
  • Focused on Neurodegenerative Diseases,  Oncology and Hospital Specialty Products
  • Internally manages portfolio through all stages of commercialization

Commercial Portfolio

VPH-Commercial-Portfolio

Here’s just a few products already approved:

BRAND: REDESCA® (BIOSIMILAR)

Launch: Q1-2021

Status: Approved by Health Canada December 2020

Indication: Injectable blood thinner

Market size:  $200M

Peak sales estimate $30 – $40M, sales margin 55 – 60% https://www.youtube.com/embed/XNn29Cx2ToY

BRAND: HESPERCOTM

Launch: Launched in Q4 -2020

Status: Approved by Health Canada

What is it: Anti-Oxidant – Immune system support

How’s it sold: Retail, Online (www.hesperco.com, www.amazon.ca)

Market Size: $500M

hesperco

BRAND: ONSTRYV®

Launch: Q3 2019

Status: Received positive recommendation for public reimbursement in Quebec

Use: Parkinson’s disease, 1st treatment launched in Canada since 2006

Patient base: 100,000 in Canada 2nd chronic neurodegenerative disorder after Alzheimer

Market Size: $20M

%Peak sales estimate $8M, sales margin 65-70 %

Pipeline

Pipeline

The Valeo Model

Company Forecast

  • All portfolio & pipeline products to be on the market by end 2022
  • Solid pipeline composed of “licensed” products
  • Peak Sales reached 2-4 years after market launch
  • From 1 product on the market to 12 in 4 years and more to come
  • Forecast excludes any new product licensing

Hub On AGORACOM / Corporate Profile

Tags: , , , , , , , , , , , ,
Posted in AGORACOM Clients (New), All Recent Posts, Featured, Valeo Pharma Inc | Comments Off on AGORACOM Welcomes Valeo Pharma $VPH.ca $VPHIF With 7 Products To Be Launched In 2021 / 2022 ($45M. Estimated Peak Sales / Year) $HLS.ca $MDP.ca $GUD.ca $RX.ca

AGORACOM Small Cap 60: $KABN.ca A #Fintech Platform Focused On Verifying, Managing & Monetizing Online Identity $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 1:09 PM on Tuesday, December 15th, 2020
kabn-square-new

GENERALLY – KABN Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.

SPECIFICALLY – KABN Specializes In

  • Continuous Online Identity Verification
  • Personal Identity Management
  • Personal Data Monetization.

NEW DIGITAL PRIVACY LAWS OVER THE LAST 2 YEARS ARE DRIVING CUSTOMERS TO KABN FOR THE FOLLOWING REASONS:

  • Your Online Privacy & Data Protection Is More Important Now Than Ever
  • Facebook Data Privacy Scandal Lead To The Implementation of GDPR (General Data Protection Regulation
  • GDPR Is Essentially EU Law On Digital Privacy That Strongly Regulates The Transfer Of Personal Data.
  • The Primary Purpose Of GDPR Is To Give Individuals Control Over Their Personal Data By Regulating All International Businesses That Handle Our Data
  • GDPR Became Effective May 25, 2018
  •  GDPR Was Followed By The California Consumer Privacy Act of 2018 (CCPA)
  • The CCPA Became Effective January 1, 2020.
  • Both Will Have A Significant Impact On The Way These Industries Collect and Capitalize On Personal Data
    • Social Media               (Facebook, Twitter, etc.)
    • E-commerce                (Amazon, Ali Baba, etc.)
    • Digital Payments         (PayPal, AliPay, etc.)
    • Cloud Computing       (AWS, Azure, etc.)
    • iGaming / Gambling    (Bet365, Tencent, Epic Games, etc.)

Hub On AGORACOM / Corporate Profile

Tags: , , , , , , , ,
Posted in AGORACOM Small Cap 60, All Recent Posts, Featured, KABN, KABN Systems NA Holdings Corp. | Comments Off on AGORACOM Small Cap 60: $KABN.ca A #Fintech Platform Focused On Verifying, Managing & Monetizing Online Identity $MOS.ca $MOGO.ca $CTZ.ca

CLIENT FEATURE: Innocan Pharma $INNO.ca Developing The Pharmaceutical Guided Missile To Defeat Coronavirus Lung Infections $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 11:38 AM on Tuesday, December 15th, 2020
Innocan-Blog

Innocan Pharma Corporation (INNO: CSE) (IP4:FSE) is developing the pharmaceutical guided missile to defeat coronavirus lung infections. The company specializes in the development of new drug platforms which combine unique properties of Cannabinoids. 

3 Fully Operating Divisions For Investor Diversification

Innocan has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

PHARMACEUTICAL – THE GUIDED MISSILE – Revolutionary technology targeting lungs infected with coronavirus or other viral infections.

CONSUMER RETAIL – DERMA COSMETICS – A premium derma cosmetics brand, manufacturing has commenced with distribution agreements in place.

OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF – patent-pending CBD pain relief brand received FDA technical validation.

Global Manufacturing / Distribution Agreements

  • Endless Sky Inc. a Canadian large scale Cannabis extractor (Manufacturing and Distribution – Canada)
  • Swiss CBD provider Cloud 9 Switzerland LLC (Distribution – Italy and Switzerland)
  • Active Therapeutics Ltd of Lancashire, United Kingdom (Distribution – UK and Ireland markets)
  • iAmHealth Distribution UG (Distribution – Germany)

Completed Trademark Registration in the EU, UK and Switzerland

  • Completion of the registration of its trademarks: Innocan Pharma, Relief & Go and SHIR in the EU, UK and Switzerland.
  • These trademarks represent Innocan’s OTC and derma cosmetic brand products that were recently launched in the German and UK markets.

Superior Management Team

In the small cap world, the jockey(s) that drive the horse are just as important as the horse itself.  The InnoCan Leadership Group Is Incomparable In The Small Cap World, Comprised Of Leading Israeli Pharmaceutical Executives including:

  • Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
  • Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
  • Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
  • Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.

Together they have built one of the most formidable teams in the small cap cannabis world

Hub On AGORACOM / Corporate Profile

Tags: , , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Innocan Pharma Corporation | Comments Off on CLIENT FEATURE: Innocan Pharma $INNO.ca Developing The Pharmaceutical Guided Missile To Defeat Coronavirus Lung Infections $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

Datametrex $DM.ca $DTMXF Awarded Two Contracts with Insurance Provider and Airport Authority $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:51 AM on Tuesday, December 15th, 2020
  • Announced that it has been awarded two AI related contracts totalling $150,000 on the initial pilot contracts.
  • The first contract is for tech support for Incheon International Airport Corporation, a major airport in the Republic of Korea.
  • Company was also awarded a contract with ABL Life Insurance Co., Ltd. for job automation scheduling.
  • The Company commenced the work, and is already in negotiation to expand the scope of work and contract.

Toronto, Ontario–(December 15, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has been awarded two AI related contracts totalling $150,000 on the initial pilot contracts.

The first contract is for tech support for Incheon International Airport Corporation (“IIAC”), a major airport in the Republic of Korea.

Under the terms of the contract, Datametrex will provide AI for job automation scheduling using AI technologies in partnership with third party software from Sees solutions for Workload Automation-As-A-Service (“WAAAS”). The batch job scheduler will help automate the workflow with all batch jobs that are software managed and approve the results of the execution by WAAAS. Integrated batch job scheduler systems are linked to the existing legacy system and each target system is configured to execute batch jobs. Once operational, the system will feature integrated batch job management, flexible approval system, efficient calendar management, secure security, optimal performance, and agent add-in are features that manage file transfer functions.

The Company was also awarded a contract with ABL Life Insurance Co., Ltd. (“ABL”) for job automation scheduling. The Company commenced the work, and is already in negotiation to expand the scope of work and contract.

About Incheon International Airport Corporation

Seoul Airport, known officially as Incheon International Airport (IATA: ICN, ICAO: RKSI), and is the largest and the primary airport serving Seoul, the capital of South Korea. The airport employs over 40,000 people and include airport management staff, security personnel and system managers.

It is located west of Incheon city and 30 miles (48 km) west of Seoul. Incheon Airport consists of two passenger terminals, and has 111 boarding gates altogether, with 44 in Terminal 1, 30 in Concourse A (connected to Terminal 1), and 37 in Terminal 2. It has been rated as the one of the world’s cleanest airports and highly rated international transit airports by Skytrax. In 2019, the airport served a total of 70,857,908 passengers and ranked 8th in international passengers and 3rd in international cargo. Additional information on Incheon is available at www.airport.kr/

About ABL Life Insurance Co., Ltd

Founded in 1954, ABL Life provides insurance products and financial services to 1.13 million customers based on a nationwide sales network. ABL Life Insurance is striving to become “a reliable global life insurance company that provides ‘better life’ through advanced products and smart services.” Additional information on ABL is available at www.abllife.co.kr/

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

###

Tags: , , , , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca $DTMXF Awarded Two Contracts with Insurance Provider and Airport Authority $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

« Older Entries
Newer Entries »